Parkinson's disease ► Public Health Genomics Knowledge Base (v1.0)

Public Health Genomics Knowledge Base (v1.0)








Last Updated: May 19, 2016

• Association of Dopamine Beta-Hydroxylase (DBH) Polymorphisms with Susceptibility to Parkinson's Disease.
  Shao Peng, et al. Medical science monitor : international medical journal of experimental and clinical research 2016 0 1617-22
• PARK16 is associated with PD in the Malaysian population.
  Gopalai Aroma Agape, et al. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2016 5
• Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease?
  Yarnall Alison J, et al. Movement disorders : official journal of the Movement Disorder Society 2016 5 (5) 668-75
• A Polymorphic Antioxidant Response Element Links NRF2/sMAF Binding to Enhanced MAPT Expression and Reduced Risk of Parkinsonian Disorders.
  Wang Xuting, et al. Cell reports 2016 4
• hVMAT2: A Target of Individualized Medication for Parkinson's Disease.
  Xiong Nian, et al. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2016 5
• The association between the LRRK2 R1628P variant and the risk of Parkinson's disease in Asian: a meta-analysis.
  Wang Xiaoli, et al. Neuroscience letters 2016 4 22-27
• DCTN1 p.K56R in progressive supranuclear palsy.
  Gustavsson Emil K, et al. Parkinsonism & related disorders 2016 4
• No association of GPNMB rs156429 polymorphism with Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy in Chinese population.
  Xu YaQian, et al. Neuroscience letters 2016 4 113-117
• SEPT14 Is Associated with a Reduced Risk for Parkinson's Disease and Expressed in Human Brain.
  Rozenkrantz Liron, et al. Journal of molecular neuroscience : MN 2016 4
• Parkinson's disease: Guilt by genetic association.
  by Asa Abeliovich & Herve Rhinn, Nature News, April 20, 2016
• Association Analysis of Proteasome Subunits and Transporter Associated with Antigen Processing on Chinese Patients with Parkinson's Disease.
  Mo Ming-Shu, et al. Chinese medical journal 0 0 (9) 1053-1058
• Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
  Benitez Bruno A, et al. Molecular neurodegeneration 2016 0 (1) 29
• ?-synuclein genetic variability: A biomarker for dementia in Parkinson's disease.
  Guella Ilaria, et al. Annals of neurology 2016 4
• Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease.
  Marras Connie, et al. Movement disorders : official journal of the Movement Disorder Society 2016 4
• The GBA, DYRK1A and MS4A6A polymorphisms influence the age at onset of Chinese Parkinson patients.
  Fan Kuan, et al. Neuroscience letters 2016 4 133-136
• MC1R variants in Chinese Han patients with sporadic Parkinson's disease.
  Shi Chang-He, et al. Neurobiology of aging 2016 3
• Glutathione S-transferase M1 polymorphisms and Parkinson's disease risk: a meta-analysis.
  Wang Dan, et al. Neurological research 2016 3 1-7
• Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease.
  Kraemmer Julia, et al. Journal of neurology, neurosurgery, and psychiatry 2016 4
• APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.
  Paul Kimberly C, et al. Journal of Parkinson's disease 2016 4
• Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers.
  Vilas Dolores, et al. Movement disorders : official journal of the Movement Disorder Society 2016 4
• Genetic analysis of FGF20 variants in Chinese Han patients with essential tremor.
  Yuan Lamei, et al. Neuroscience letters 2016 3
• Disclosure of research results in genetic studies of Parkinson's disease caused by LRRK2 mutations.
  Pont-Sunyer Claustre et al. Movement disorders : official journal of the Movement Disorder Society 2015 Jun 30(7) 904-8
• Possible association of CCDC62 rs12817488 polymorphism and Parkinson's disease risk in Chinese population: a meta-analysis.
  Lu Yanjun, et al. Scientific reports 2016 0 23991
• Influence of genetic, biological and pharmacological factors on levodopa dose in Parkinson's disease.
  Altmann Vivian, et al. Pharmacogenomics 2016 3
• Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.
  Mok Kin Y, et al. The Lancet. Neurology 2016 3
• Protective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity.
  Nixon-Abell Jonathon, et al. Frontiers in molecular neuroscience 2016 0 18
• Analysis of PRKN Variants and Clinical Features in Polish Patients with Parkinson's Disease.
  Oczkowska Anna, et al. Current genomics 2015 8 (4) 215-23
• Exonic rearrangements in the known Parkinson's disease-causing genes are a rare cause of the disease in South African patients.
  van der Merwe Celia, et al. Neuroscience letters 2016 3 168-171
• Poly (ADP-ribose) polymerase-1 (PARP-1) -410C/T polymorphism in Sicilian patients with Parkinson's disease.
  Salluzzo Maria Grazia, et al. Journal of the neurological sciences 2016 4 95-6
• Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD).
  Williams-Gray Caroline H, et al. Movement disorders : official journal of the Movement Disorder Society 2016 3

• CDC Information (0)
• CDC-Authored Pub (2)

• Human (0)
• Pathogen (2)

• Human (1704)
• Pathogen (0)

• Human (8)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB